TL;DR
This study reveals that performing ureteroscopy (URS) before radical nephroureterectomy (RNU) for upper tract urothelial carcinoma (UTUC) significantly increases the risk of bladder cancer recurrence. The findings suggest a need for careful consideration of URS in the diagnostic pathway to optimize patient outcomes.
What Problem Does This Paper Address?
Upper tract urothelial carcinoma (UTUC) is a rare but aggressive cancer. Radical nephroureterectomy (RNU) is the standard treatment, but a significant concern after this surgery is the recurrence of cancer within the bladder (intravesical recurrence or IVR). Diagnostic ureteroscopy (URS) is often used to visualize and biopsy suspicious lesions in the upper urinary tract before RNU. However, there's an ongoing debate about whether performing URS itself might inadvertently spread cancer cells to the bladder, thereby increasing the risk of IVR. Previous studies have yielded conflicting results, often due to limitations like small sample sizes or single-center data. This paper aims to clarify this association by analyzing data from a large, international, multi-center registry.
Methods
The researchers utilized data from the Clinical Research Office of the Endourology Society Urothelial Carcinomas of the Upper Tract (CROES-UTUC) registry, a prospective, multicenter database. They included 269 patients diagnosed with non-metastatic UTUC who underwent RNU and had sufficient follow-up data. Patients were divided into two groups: those who had RNU upfront and those who underwent diagnostic URS before RNU. The primary outcome measured was intravesical recurrence-free survival (IVRS), assessed using Kaplan-Meier analysis and multivariate Cox regression. Statistical analyses were performed to identify factors associated with IVRS, with a p-value of less than 0.05 considered statistically significant.
Datasets
The study used data from the Clinical Research Office of the Endourology Society Urothelial Carcinomas of the Upper Tract (CROES-UTUC) registry. This is a prospective, multicenter, international database that includes data from 29 participating centers across 101 countries. The dataset comprised 269 patients with UTUC who underwent RNU.
Key Insights and Ideas
- URS as a potential "seeding" mechanism: The study provides strong evidence that the diagnostic procedure of URS, rather than just the underlying UTUC, might contribute to bladder recurrence. This challenges the notion of URS as a purely benign diagnostic step.
- The risk is independent of auxiliary procedures: Interestingly, common adjuncts to URS, such as ureteric access sheath use, flexible ureteroscopy, ureteric biopsy, and retrograde contrast studies, did not independently influence the risk of bladder recurrence. This suggests the risk is primarily linked to the URS procedure itself.
- Need for careful clinical decision-making: The findings highlight a critical trade-off. While URS can provide diagnostic certainty, it comes with a quantifiable increased risk of a problematic complication (bladder recurrence). This necessitates a more nuanced approach to deciding when URS is truly essential.
Key Results
- A total of 269 patients were analyzed, with 137 (50.9%) in the upfront RNU group and 132 (49.1%) in the pre-RNU URS group.
- The URS group showed an inferior 24-month intravesical recurrence-free survival (IVRS) compared to the upfront RNU group.
- The hazard ratio for recurrence in the URS group was 1.705 (95% CI = 1.082–2.688; p = 0.020).
- Multivariate analysis confirmed pre-operative ureteroscopy as the sole statistically significant predictor of increased intravesical bladder recurrence (p = 0.019).
- At 24 months, IVRS rates were 64% for the upfront RNU group and 52% for the ureteroscopy group.
- Factors like ureteric access sheath usage, flexible ureteroscopy, ureteric biopsy, retrograde contrast studies, and the duration of URS did not significantly affect IVRS.
Limitations and Future Work
The authors acknowledge several limitations:
- Retrospective nature: While the registry is prospective, the analysis of the data was retrospective.
- Lack of standardization: The diagnostic URS procedures were not standardized across the numerous participating centers, which could introduce variability.
- Unobserved confounders: Despite robust analysis, the retrospective nature means unobserved confounders might still influence the results.
- Limited data on certain aspects: The study noted limitations in data regarding the adoption of intravesical chemotherapy post-RNU and specific operative details of RNU.
Future work suggested includes:
- Prospective studies: The authors emphasize the need for future prospective studies, ideally with multi-arm designs, to further investigate the nuances of URS and its auxiliary procedures.
- Investigating mechanisms: More research is needed to fully understand the mechanisms by which URS might lead to bladder recurrence.
- Role of pre-operative intravesical chemotherapy: The role of post-URS intravesical chemotherapy needs further study.
Summary updated